Skip to main content
SpringerLink
Log in

Renal Dysfunction in Hepatic Failure

  • Chapter
  • First Online:
Anesthesia and Perioperative Care for Organ Transplantation

  • 2256 Accesses

Abstract

Renal function impairment is a frequent occurrence in chronic or acute hepatic failure. The consequences of renal involvement may have an adverse impact on patient outcomes by damaging distant organs, further worsening hepatic function. Most patients with cirrhosis, especially those with ascites, have at least one form of renal impairment. In this chapter, we discuss the etiology, pathophysiology, diagnosis, and types of renal involvement in patients with end-stage liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Verna EC, Wagener G. Renal interactions in liver dysfunction and failure. Curr Opin Crit Care. 2013;19:133–41.

    Article  PubMed  Google Scholar 

  2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.

    Article  PubMed  PubMed Central  Google Scholar 

  3. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1–266.

    Google Scholar 

  4. Wong F, Nadium MK, Kellum JA, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60:702–9.

    Article  PubMed  Google Scholar 

  5. Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. ADQI Workgroup 2012;16:R23.

    Google Scholar 

  6. Mayer GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the laboratory Working Group of the National Kidney disease Education Program. Clin Chem. 2006;52:5–18.

    Article  Google Scholar 

  7. Poge U, Gerhardt T, Palmedo H, et al. MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant. 2005;5:1306–11.

    Article  PubMed  Google Scholar 

  8. Sola E, Gines P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53:1135–45.

    Article  PubMed  Google Scholar 

  9. Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol. 2010;16:347–52.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stadlbauer V, Wright GA, Banaji M, et al. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology. 2008;134:111–9.

    Article  PubMed  Google Scholar 

  11. Grace JA, Herath CB, Mak KY, Burrell LM, Angus PW. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. Clin Sci (Lond). 2012;123:225–39.

    Article  CAS  Google Scholar 

  12. Grace JA, Klein S, Herath CB, et al. Activation of the MAS receptor by angiotensin-(1–7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. Gastroenterology. 2013;145:874–84.

    Article  CAS  PubMed  Google Scholar 

  13. Töx U, Steffen HM. Impact of inhibitors of the Renin-Angiotensin-aldosterone system on liver fibrosis and portal hypertension. Curr Med Chem. 2006;13:3649–61.

    Article  PubMed  Google Scholar 

  14. Herath CB, Grace JA, Angus PW. Therapeutic potential of targeting renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol. 2013;4:1–11.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin-angiotensin system. J Endocrinol 2013 Jan Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2013;216:R1–17.

    CAS  Google Scholar 

  16. Møller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol. 2001;36:785–94.

    Article  PubMed  Google Scholar 

  17. Wong F, Siu S, Liu P, Blendis LM. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis. Clin Sci (Lond). 2001;101:621–8.

    Article  CAS  Google Scholar 

  18. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 1996;110:1191–8.

    Article  CAS  PubMed  Google Scholar 

  19. Baldassarre M, Giannone FA, Napoli L, et al. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. Liver Int. 2013;33:1298–308.

    Article  CAS  PubMed  Google Scholar 

  20. Karagiannakis DS, Vlachogiannakos J, et al. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci. 2013;58:3029–36.

    Article  CAS  PubMed  Google Scholar 

  21. Serna E, Mauricio MD, Lluch P, et al. Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: role of dimethylarginine dimethylaminohydrolase. J Gastroenterol Hepatol. 2013;28:880–6.

    Article  CAS  PubMed  Google Scholar 

  22. Schwedhelm E, Böger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7:275–85.

    Article  CAS  PubMed  Google Scholar 

  23. Lluch P, Mauricio MD, Vila JM, et al. Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp Biol Med. 2006;231:70–5.

    CAS  Google Scholar 

  24. Rimola A, Gines P, Arroyo V, et al. Urinary excretion of 6-keto-prostaglandin F 1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). J Hepatol. 1986;3:111–7.

    Article  CAS  PubMed  Google Scholar 

  25. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspective in the age of MELD. Hepatology. 2003;37:233–43.

    Article  PubMed  Google Scholar 

  26. Gines P, Guevera M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet. 2003;362:1819–27.

    Article  CAS  PubMed  Google Scholar 

  27. Wagener G, Gubitosa G, Wang S, et al. Urinary neutrophil gelatinase associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2008;52:425–33.

    Article  CAS  PubMed  Google Scholar 

  28. Wadei HM, Mai ML, Ahsan N, et al. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol. 2006;1:1066–79.

    Article  CAS  PubMed  Google Scholar 

  29. Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol Hepatol. 2002;17:882–8.

    Article  Google Scholar 

  30. Garcia-Tsao G. Bacterial infection in cirrhosis. Can J Gastroenterol. 2004;18:405–6.

    Article  PubMed  Google Scholar 

  31. Alessandria C, Ozdogan O, Guevera M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41:1282–9.

    Article  PubMed  Google Scholar 

  32. Li YC, Shih YM, Lee JA. Gentamicin caused renal injury deeply related to methylglyoxal and N(ɛ)-(carboxyethyl)lysine (CEL). Toxicol Lett. 2013;219:85–92.

    Article  CAS  PubMed  Google Scholar 

  33. Westphal JF, Jehl F, Vetter D. Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver. Clin Infect Dis. 1994;18:324–35.

    Article  CAS  PubMed  Google Scholar 

  34. Geenen RW, Kingma HJ, van der Molen AJ. Contrast-induced nephropathy: pharmacology, pathophysiology and prevention. Insights Imaging. 2013;4:811–20.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Johnson RJ, Wilson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994;46:1255–63.

    Article  CAS  PubMed  Google Scholar 

  36. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24:198–211.

    Article  CAS  PubMed  Google Scholar 

  37. Kalambokis G, Christou L, Stefanou D, Arkoumani E, Tsianos EV. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol. 2007;13:5783–6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol. 2011;170:36–47.

    Article  PubMed  Google Scholar 

  39. Sherman DS, Fish DN, Tietelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41:268–78.

    Article  Google Scholar 

  40. Caregaro L, Menon F, Angeli P, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994;154:201–5.

    Article  CAS  PubMed  Google Scholar 

  41. Kuster N, Bargnoux AS, Pageaux GP, Cristol JP. Limitations of compensated Jaffe creatinine assays in cirrhotic patients. Clin Biochem. 2012;45:320–5.

    Article  CAS  PubMed  Google Scholar 

  42. Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012;57:2362–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ustundag Y, Samsar U, Acikgoz S, et al. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med. 2007;45:890–4.

    Article  CAS  PubMed  Google Scholar 

  44. Manabe K, Kamihata H, Motohiro M, et al. Urinary liver-type fatty acid-binding protein as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest. 2012;42:557–63.

    Article  CAS  PubMed  Google Scholar 

  45. Han WK, Bailly V, Abrichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a noval renal proximal tubules injury. Kidney Int. 2002;62:237–44.

    Article  CAS  PubMed  Google Scholar 

  46. Ginès P, Torre A, Terra C, Guevara M. Review article: pharmacological treatment of hepatorenal syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 3:57–62.

    Article  PubMed  Google Scholar 

  47. Cobas M, Paparcuri G, De La Pena M, et al. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study. Cardiovasc Ther. 2011;29:280–4.

    Article  CAS  PubMed  Google Scholar 

  48. Karthik S, Lisbon A. Low-dose dopamine in the intensive care unit. Semin Dial. 2006;19:465–71.

    Article  PubMed  Google Scholar 

  49. Cavalcanti AB, De Vasconcelos CP, Perroni de Oliveira M, et al. Prostaglandins for adult liver transplanted patients. Cochrane Database Syst Rev. 2011;11, CD006006.

    Google Scholar 

  50. Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:523–30.

    Article  PubMed  Google Scholar 

  51. Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012;33:144–8.

    Article  PubMed  Google Scholar 

  52. Lavayssière L, Kallab S, Cardeau-Desangles I, et al. Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure. J Gastroenterol Hepatol. 2013;28:1019–24.

    Article  PubMed  Google Scholar 

  53. Gainza FJ, Valdivieso A, Quintanilla N, et al. Evaluation of acute renal failure in liver transplantation perioperative period: incidence and impact. Transplant Proc. 2002;34:250–1.

    Article  CAS  PubMed  Google Scholar 

  54. Karapanagiotou A, Kydona C, Dimitriadis C, Sgourou K, Giasnetsova T, Fouzas I, Imvrios G, Gritsi-Gerogianni N. Acute kidney injury after orthotopic liver transplantation. Transplant Proc. 2012;44:2727–9.

    Article  CAS  PubMed  Google Scholar 

  55. Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut. 2013;62:131–7.

    Article  PubMed  Google Scholar 

  56. de Carvalho JR, Villela-Nogueira CA, Luiz RR, et al. Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites. Clin Gastroenterol. 2012;46:e21–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Presbyterian Hospital, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA, 15213, USA

    Ibtesam A. Hilmi M.B.Ch.B., F.R.C.A.

  2. Department of Anesthesiology, Allegheny General Hospital, Pittsburgh, PA, USA

    Ali R. Abdullah M.B.Ch.B.

Authors
  1. Ibtesam A. Hilmi M.B.Ch.B., F.R.C.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali R. Abdullah M.B.Ch.B.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ibtesam A. Hilmi M.B.Ch.B., F.R.C.A. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Kathirvel Subramaniam

  2. Department of Anesthesiology The Clinical and Translational Science Institute The McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Tetsuro Sakai

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hilmi, I.A., Abdullah, A.R. (2017). Renal Dysfunction in Hepatic Failure. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_34

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation